Andrea R. Genazzani
ORCID: 0000-0003-4260-3929
· 5 papers in corpus
guideline
2026
Extending women's health-span is a key challenge for the medical community. Although women live longer than men, they face a higher burden of chronic diseases, such as cardiovascular diseases (CVDs) and disabilities. Endogenous estrogens ap…
2020
A randomized control trial of 64 hyperprolactinemic women with Recurrent Pregnancy Loss (RPL) treated with bromocriptine showed a higher incidence of live births, while PRL levels were significantly higher in women who miscarried. Progester…
review
2018
More empathized approach is required and is obligatory to women with premature ovarian insufficiency (POI) interested for pregnancy. In order to improve fertility rate in POI patients our suggestions would be: (1) To decrease FSH value to 1…
observational
2008
BACKGROUND: It has become increasingly clear that the follicular microenvironment of the maturing human oocyte is a determining factor for the implantation potential of an embryo deriving from that oocyte. Indeed the quality and maturity of…
rct
2007
OBJECTIVE: To evaluate the safety and endometrial protection of low-dose transdermal estradiol (E2)/norethisterone acetate (NETA) patches (Estalis 25/125) in terms of post-treatment incidence of endometrial hyperplasia/cancer after 1 year o…